title: Reversible aphasic disorder induced by lamotrigine in atypical benign childhood epilepsy.
abstract: OBJECTIVE
  We studied an eleven year-old girl with atypical, benign partial epilepsy who acutely presented a severe aphasia associated with marked EEG deterioration after lamotrigine administration. A parallel monitoring of language disorders and EEG changes during the gradual withdrawal of lamotrigine was performed in order to evaluate their possible correlation with lamotrigine administration.
  
  
  METHODS
  Detailed neuropsychological and linguistic examinations in association with awake and sleep EEG were periodically performed.
  
  
  RESULTS
  The evolution of the aphasic disorder was closely related to the EEG abnormalities, and disappeared after the withdrawal of lamotrigine.
  
  
  CONCLUSIONS
  We considered the hypothesis that our case could be an expression of a paradoxical reaction to lamotrigine, in which the transitory aphasic disorder was sustained by an epileptiform electric activation.
authors.affiliation: Neuropsichiatria Infantile, UCSC, Policlinico Gemelli, Largo Gemelli 8, 00168, Rome, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Battaglia
authors.forename: L
authors.initials: L
authors.lastname: Iuvone
authors.forename: M C
authors.initials: MC
authors.lastname: Stefanini
authors.forename: C
authors.initials: C
authors.lastname: Acquafondata
authors.forename: D
authors.initials: D
authors.lastname: Lettori
authors.forename: F
authors.initials: F
authors.lastname: Chiricozzi
authors.forename: M
authors.initials: M
authors.lastname: Pane
authors.forename: A
authors.initials: A
authors.lastname: Mittica
authors.forename: F
authors.initials: F
authors.lastname: Guzzetta
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001037:Aphasia / Q000139:chemically induced*; D002648:Child; D004569:Electroencephalography / Q000187:drug effects; D004832:Epilepsy, Absence / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use; D014888:Wechsler Scales
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D014635:Valproic Acid; D000077213:Lamotrigine